(Q50787818)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Long-term clinical experience with weekly interferon beta-1a in relapsing multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Giuseppe Orefice

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

G Coppola

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

C Florio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

P Vivo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

S Ascione

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

V Schiavone

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

A Pagano

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

G Vacca

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

G De Michele

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

V Brescia Morra

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Neurology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1014-1021

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

Interferons in relapsing remitting multiple sclerosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

The natural history of multiple sclerosis: implications for trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

Hepatic injury, liver monitoring and the beta-interferons for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

Liver and thyroid function and autoimmunity during interferon-beta 1b treatment for MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

Haematological effects of interferon-beta-1a (Rebif) therapy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

Natural history of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

Steroid correlates of territorial behavior in male jacky dragons, Amphibolurus muricatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

Design strategies in multiple sclerosis clinical trials. The Cyclosporine Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon β: Implications for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01422.X

10.1111/J.1468-1331.2006.01422.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16930370%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference